Seroatlas · Human Serome Atlas

SLC25A13

Electrogenic aspartate/glutamate antiporter SLC25A13, mitochondrial

Also known as: ARALAR2, CITRIN, CTLN2, S2513_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9UJS0
Gene
SLC25A13
Ensembl
ENSG00000004864
Chromosome
7
Canonical length
675 aa
Protein class
Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
Subcellular location
Mitochondria
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]

Canonical amino-acid sequenceUniProt

675 residues, UniProt reviewed canonical sequence.

>Q9UJS0|SLC25A13
     1  MAAAKVALTK RADPAELRTI FLKYASIEKN GEFFMSPNDF VTRYLNIFGE SQPNPKTVEL
    61  LSGVVDQTKD GLISFQEFVA FESVLCAPDA LFMVAFQLFD KAGKGEVTFE DVKQVFGQTT
   121  IHQHIPFNWD SEFVQLHFGK ERKRHLTYAE FTQFLLEIQL EHAKQAFVQR DNARTGRVTA
   181  IDFRDIMVTI RPHVLTPFVE ECLVAAAGGT TSHQVSFSYF NGFNSLLNNM ELIRKIYSTL
   241  AGTRKDVEVT KEEFVLAAQK FGQVTPMEVD ILFQLADLYE PRGRMTLADI ERIAPLEEGT
   301  LPFNLAEAQR QKASGDSARP VLLQVAESAY RFGLGSVAGA VGATAVYPID LVKTRMQNQR
   361  STGSFVGELM YKNSFDCFKK VLRYEGFFGL YRGLLPQLLG VAPEKAIKLT VNDFVRDKFM
   421  HKDGSVPLAA EILAGGCAGG SQVIFTNPLE IVKIRLQVAG EITTGPRVSA LSVVRDLGFF
   481  GIYKGAKACF LRDIPFSAIY FPCYAHVKAS FANEDGQVSP GSLLLAGAIA GMPAASLVTP
   541  ADVIKTRLQV AARAGQTTYS GVIDCFRKIL REEGPKALWK GAGARVFRSS PQFGVTLLTY
   601  ELLQRWFYID FGGVKPMGSE PVPKSRINLP APNPDHVGGY KLAVATFAGI ENKFGLYLPL
   661  FKPSVSTSKA IGGGP

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against SLC25A13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
6
Mean surface accessibility (rSASA)
0.28
Highest tissue expression
140 nTPM

Expression across tissuesHPA

Tissue

  • liver: 140 nTPM
  • kidney: 30 nTPM
  • spinal cord: 18 nTPM
  • retina: 18 nTPM
  • rectum: 17 nTPM
  • colon: 15 nTPM

Single-cell type

  • oligodendrocytes: 485 nCPM
  • neutrophils: 470 nCPM
  • choroid plexus epithelial cells: 434 nCPM
  • retinal pigment epithelial cells: 375 nCPM
  • hepatocytes: 366 nCPM
  • pituitary stem cells: 274 nCPM

Immune cell

  • myeloid DC: 6.1 nTPM
  • non-classical monocyte: 5.1 nTPM
  • intermediate monocyte: 4.5 nTPM
  • classical monocyte: 3.1 nTPM
  • plasmacytoid DC: 3.1 nTPM
  • memory B-cell: 2.4 nTPM

Brain region

  • white matter: 38 nTPM
  • choroid plexus: 28 nTPM
  • cerebellum: 25 nTPM
  • medulla oblongata: 25 nTPM
  • basal ganglia: 25 nTPM
  • pons: 23 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about SLC25A13.

Disease | AllUniProt

Conditions SLC25A13 is implicated in, by any mechanism.

Disease | GeneticClinVar

213 pathogenic / likely-pathogenic of 997 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.24
gnomAD pLI
0
gnomAD missense Z
0.3
DepMap mean gene effect
0.04
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of SLC25A13 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads SLC25A13 as an antibody target. Whether an autoantibody or antibody against SLC25A13 could matter depends on whether native SLC25A13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

SLC25A13 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label SLC25A13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/SLC25A13. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...